1. Home
  2. ALIM vs PANL Comparison

ALIM vs PANL Comparison

Compare ALIM & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALIM
  • PANL
  • Stock Information
  • Founded
  • ALIM 2003
  • PANL 1996
  • Country
  • ALIM United States
  • PANL United States
  • Employees
  • ALIM N/A
  • PANL N/A
  • Industry
  • ALIM Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • ALIM Health Care
  • PANL Consumer Discretionary
  • Exchange
  • ALIM Nasdaq
  • PANL Nasdaq
  • Market Cap
  • ALIM 304.0M
  • PANL 311.9M
  • IPO Year
  • ALIM 2010
  • PANL N/A
  • Fundamental
  • Price
  • ALIM $5.56
  • PANL $6.21
  • Analyst Decision
  • ALIM Hold
  • PANL Strong Buy
  • Analyst Count
  • ALIM 3
  • PANL 1
  • Target Price
  • ALIM $6.00
  • PANL N/A
  • AVG Volume (30 Days)
  • ALIM 929.8K
  • PANL 139.0K
  • Earning Date
  • ALIM 10-24-2024
  • PANL 11-06-2024
  • Dividend Yield
  • ALIM N/A
  • PANL 6.44%
  • EPS Growth
  • ALIM N/A
  • PANL N/A
  • EPS
  • ALIM N/A
  • PANL 0.77
  • Revenue
  • ALIM $99,681,000.00
  • PANL $503,739,510.00
  • Revenue This Year
  • ALIM $33.90
  • PANL $6.68
  • Revenue Next Year
  • ALIM $14.22
  • PANL $11.47
  • P/E Ratio
  • ALIM N/A
  • PANL $8.09
  • Revenue Growth
  • ALIM 69.78
  • PANL N/A
  • 52 Week Low
  • ALIM $2.61
  • PANL $5.28
  • 52 Week High
  • ALIM $5.65
  • PANL $9.53
  • Technical
  • Relative Strength Index (RSI)
  • ALIM 53.85
  • PANL 32.58
  • Support Level
  • ALIM $5.57
  • PANL $6.68
  • Resistance Level
  • ALIM $5.62
  • PANL $6.88
  • Average True Range (ATR)
  • ALIM 0.03
  • PANL 0.16
  • MACD
  • ALIM -0.32
  • PANL -0.01
  • Stochastic Oscillator
  • ALIM 98.76
  • PANL 8.22

About ALIM Alimera Sciences Inc.

Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. The company commercializes ILUVIEN in the U.S., Europe, China and the Middle East operations are managed as three operating segments: U.S., International and Operating Cost It generates maximum revenue from U.S. Segment.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.

Share on Social Networks: